Yahoo

Has LANXESS (XTRA:LXS) Fallen Far Enough to Be a Bargain?

LANXESS has seen its share price fall sharply in recent years, which puts fresh focus on whether the current €12.48 level is reasonable when set against its sales. For anyone still tracking the stock, the key puzzle is how much of the past share price decline is already reflected in what the business generates in revenue today.

  • Over the past 5 years the stock has fallen 76.8%, which puts serious weight on the question of how the market now values each euro of LANXESS' sales.

  • With investor attention likely to rest on execution, any shift in LANXESS' ability to convert revenue into cash or manage its balance sheet can influence how much investors are willing to pay per unit of sales.

  • The analysts covering LANXESS have run their own numbers. See what analysts think LANXESS's shares could be worth .

The issue now is whether LANXESS' current share price is properly supported by its sales when compared with the Fair Ratio benchmark.

If you are weighing whether LANXESS at €12.48 still fits your playbook on sales-based valuations, it can help to compare that setup with companies in the 178 high quality undervalued stocks

Is LANXESS Still Cheap on Sales?

P/S suits LANXESS because revenue is still a meaningful anchor even when earnings move around. On this yardstick, the stock trades on a P/S of 0.2x, which is far below the Chemicals industry average of 1.3x. The figure also sits well under the 0.6x level seen across closer peers, so the market is currently attaching a relatively low value to each euro of the company's sales.

The Fair Ratio model, which aligns the sales multiple with LANXESS' own scale, margins, sector and risk profile, points to a higher P/S than the current level. That gap suggests the shares screen as undervalued on this framework and that the present price reflects a cautious view of how much investors are willing to pay per unit of revenue. Explore the numbers behind LANXESS's P/S valuation .

XTRA:LXS P/S Ratio as at Oct 2026
XTRA:LXS P/S Ratio as at Oct 2026

The LANXESS Narrative: What Would Justify Today's Price?

Narratives pick up where the P/S puzzle for LANXESS leaves off and spell out which mix of future growth, profitability and earnings paths would need to play out for the share price to sit meaningfully higher or lower than today, all housed on Simply Wall St's Community page. Each scenario anchors its number to a clear view on how LANXESS' growth, margins and risk profile might evolve. This gives you something concrete to revisit when fresh information arrives.

LANXESS inspires two very different readings from the community, split between a recovery story and a more cautious reset case.

Bull case: 26% undervalued

"Strategic portfolio optimization including the divestiture of the urethane business, accelerated closure of high-cost, high-CO2 assets, and network consolidation positions LANXESS to allocate capital toward higher-margin, resilient segments..."

Discover why this Narrative puts LANXESS at 26% undervalued .

Bear case: 13% overvalued

"Intensifying competition from low-cost Asian producers, particularly from China, continues to result in price erosion and dumping in core European markets..."

Explore why this Narrative puts LANXESS at 13% overvalued .

LANXESS' price is only one piece of the puzzle

Share price and sales multiples tell part of the LANXESS story, but broker models that map out where earnings and cash flows might head over the next few years offer a different lens to compare with today. Explore where analysts expect LANXESS to be in a few years .

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include LXS.DE .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: